U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. Preparation of IDEs and INDs for Products Intended to Repair or Replace Knee Cartilage
  1. Search for FDA Guidance Documents

GUIDANCE DOCUMENT

Preparation of IDEs and INDs for Products Intended to Repair or Replace Knee Cartilage Guidance for Industry December 2011

Download the Final Guidance Document Read the Federal Register Notice
Final
Docket Number:
FDA-2007-D-0020
Issued by:
Guidance Issuing Office
Center for Biologics Evaluation and Research

This guidance document provides to you, sponsors of an investigational device exemption application (IDE) or an investigational new drug application (IND), recommendations about certain information that should be included in a submission describing a product intended to repair or replace knee cartilage. For the purposes of this document, a product intended to repair or replace knee cartilage, as with other cartilage repair or replacement products,1 may include a biologic, device, or combination product2 whose components would individually be regulated by the Center for Devices and Radiological Health (CDRH) or the Center for Biologics Evaluation and Research (CBER).3,4 This guidance finalizes the draft guidance of the same title dated July 2007.

Submit Comments

Submit Comments Online

You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))

If unable to submit comments online, please mail written comments to:

Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852

All written comments should be identified with this document's docket number: FDA-2007-D-0020.

Questions?

Back to Top